Skip to main content
TipRanks
Go Ultimate75% OFF

Hanall Biopharma Co., Ltd. (009420) Cash flow

Hanall Biopharma Co., Ltd. Cash Flow

KR:009420's free cash flow for Q3 2026 was ₩1.66B. For the 2026 fiscal year, KR:009420's free cash flow was decreased by ₩-12.60M and operating cash flow was ₩1.67B. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
₩ -2.34B₩ 9.36B₩ 29.64B₩ 25.20B₩ 839.87M
₩ -18.83B₩ -27.49B₩ -11.89B₩ -10.59B₩ 8.03B
₩ 29.57B₩ 759.59M₩ -813.51M₩ -10.64B₩ -306.53M
₩ 24.74B₩ 16.39B₩ 33.72B₩ 16.84B₩ 12.79B
₩ -3.29B₩ -13.71B₩ 20.45B₩ 17.53B₩ -8.16B

Currency in KRW

Hanall Biopharma Co., Ltd. Cash Flow

-60B-40B-20B020B40B60B201720182019202020212022202320242025OperatingInvestingFinancing